Compare · CNMD vs NRXS
CNMD vs NRXS
Side-by-side comparison of CONMED Corporation (CNMD) and Neuraxis Inc. (NRXS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and NRXS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- CNMD is the larger of the two at $1.16B, about 13.1x NRXS ($87.9M).
- Over the past year, CNMD is down 24.2% and NRXS is up 241.6% - NRXS leads by 265.8 points.
- NRXS has been more active in the news (5 items in the past 4 weeks vs 2 for CNMD).
- CNMD has more recent analyst coverage (14 ratings vs 0 for NRXS).
- Company
- CONMED Corporation
- Neuraxis Inc.
- Price
- $38.56+0.39%
- $7.96+1.27%
- Market cap
- $1.16B
- $87.9M
- 1M return
- +5.41%
- +14.53%
- 1Y return
- -24.18%
- +241.63%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- AMEX
- IPO
- 1987
- 2023
- News (4w)
- 2
- 5
- Recent ratings
- 14
- 0
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Latest CNMD
- SEC Form DEFA14A filed by CONMED Corporation
- SEC Form DEF 14A filed by CONMED Corporation
- SEC Form 4 filed by Beyer Pat
- CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by CONMED Corporation
- Amendment: SEC Form 4 filed by Lalomia Brent
- Amendment: SEC Form 4 filed by Schabacker Matthew
- Amendment: SEC Form 4 filed by Foust Hollie K
- Amendment: SEC Form 4 filed by Ferrell John D.
- Amendment: SEC Form 4 filed by Shagory Peter K
Latest NRXS
- Neuraxis Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- NeurAxis Expands Payer Coverage with Four New Medical Policies
- Neuraxis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- SEC Form 424B5 filed by Neuraxis Inc.
- NeurAxis, Inc. Announces Preferred Stock Dividend
- SEC Form 4 filed by Henrichs Timothy Robert
- SEC Form 4 filed by Carrico Thomas Joeseph
- SEC Form 4 filed by Carrico Brian Allen
- NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
- SEC Form 10-K filed by Neuraxis Inc.